BLT 0.00% 2.6¢ benitec biopharma limited

gradalis playing hardball or business as usual, page-39

  1. 169 Posts.
    I think Gradalis is waiting for positive results from the
    phase 2 trials before going back to the donors for more money plus some money for the licensing to BLT. OR maybe they were so confident of their technology that they didn't tell their backers about the licensing.
    But I think the backers and Gradalis will do by the right thing.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.